DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Innovision Limited — Awarding of order(s)/contract(s)

NSE 2 hrs ago·10 Aug 2026, 1:04 pm

INNOVISION NSE

Innovision Limited has recently informed the stock exchange about the awarding of new orders or contracts. This announcement signals that the company has secured new business, which is a positive development for its operations and growth prospects.

For investors, this news is generally viewed favorably as it indicates an increase in revenue opportunities and validates the company's market position. It suggests that the company is actively expanding its business and securing new projects.

Investors should look for further details regarding the value and duration of these new contracts. Monitoring the company's future quarterly results will be essential to gauge how these new orders impact its overall financial performance.